Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1988 1
1989 1
1990 1
1991 1
1995 4
1996 2
1999 1
2000 1
2001 1
2002 1
2003 3
2004 6
2005 5
2006 3
2007 3
2008 6
2009 5
2010 5
2011 7
2012 2
2013 4
2014 12
2015 14
2016 12
2017 8
2018 6
2019 5
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 15550119

113 results
Results by year
Filters applied: . Clear all
Page 1
Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses.
Silva DG, Cooper PD, Petrovsky N. Silva DG, et al. Immunol Cell Biol. 2004 Dec;82(6):611-6. doi: 10.1111/j.1440-1711.2004.01290.x. Immunol Cell Biol. 2004. PMID: 15550119 Review.
Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity.
Petrovsky N. Petrovsky N. Vaccine. 2006 Apr 12;24 Suppl 2(Suppl 2):S2-26-9. doi: 10.1016/j.vaccine.2005.01.107. Vaccine. 2006. PMID: 16823913 Free PMC article. Review.
Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.
Mahalakshmi N, Aparnaa R, Kaliraj P. Mahalakshmi N, et al. Scand J Immunol. 2014 Oct;80(4):261-70. doi: 10.1111/sji.12208. Scand J Immunol. 2014. PMID: 25041426 Free article.
Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y, Barnard D, Ong CH, Peng BH, Tseng CT, Petrovsky N. Honda-Okubo Y, et al. J Virol. 2015 Mar;89(6):2995-3007. doi: 10.1128/JVI.02980-14. Epub 2014 Dec 17. J Virol. 2015. PMID: 25520500 Free PMC article.
Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
Verma V, Tan W, Puth S, Cho KO, Lee SE, Rhee JH. Verma V, et al. J Transl Med. 2016 May 17;14(1):135. doi: 10.1186/s12967-016-0899-4. J Transl Med. 2016. PMID: 27184355 Free PMC article.
Suramin has adjuvant properties and promotes expansion of antigen-specific Th1 and Th2 cells in vivo.
Denkinger M, Shive CL, Pantenburg B, Forsthuber TG. Denkinger M, et al. Int Immunopharmacol. 2004 Jan;4(1):15-24. doi: 10.1016/j.intimp.2003.09.004. Int Immunopharmacol. 2004. PMID: 14975356
Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
Bielinska AU, O'Konek JJ, Janczak KW, Baker JR Jr. Bielinska AU, et al. Vaccine. 2016 Jul 25;34(34):4017-24. doi: 10.1016/j.vaccine.2016.06.043. Epub 2016 Jun 23. Vaccine. 2016. PMID: 27317451 Free PMC article.
Vaccine adjuvants: current state and future trends.
Petrovsky N, Aguilar JC. Petrovsky N, et al. Immunol Cell Biol. 2004 Oct;82(5):488-96. doi: 10.1111/j.0818-9641.2004.01272.x. Immunol Cell Biol. 2004. PMID: 15479434 Review.
Vaccine adjuvants based on gamma inulin.
Cooper PD. Cooper PD. Pharm Biotechnol. 1995;6:559-80. doi: 10.1007/978-1-4615-1823-5_24. Pharm Biotechnol. 1995. PMID: 7551236 Review.
Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
Dinc G, Pennington JM, Yolcu ES, Lawrenz MB, Shirwan H. Dinc G, et al. Vaccine. 2014 Sep 3;32(39):5035-40. doi: 10.1016/j.vaccine.2014.07.015. Epub 2014 Jul 18. Vaccine. 2014. PMID: 25045812
113 results
Jump to page
Feedback